You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 73 No. 5, May 1965 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Treatment of Human Herpes Simplex Keratitis With Idoxuridine

A Sequential Double-Blind Controlled Study

DANIEL R. L. HART, FRCS, FRACS; VERNON J. F. BRIGHTMAN, MDSc, PhD; GRAHAM G. READSHAW, MB, BS; GEOFFREY T. J. PORTER, MB, BS; MARY J. TULLY, BSc

Arch Ophthalmol. 1965;73(5):623-634.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Introduction

The original report of Kaufman et al,1 describing treatment of human herpes simplex keratitis with idoxuridine (5-iodo-2'-deoxyuridine, IDU) was followed by a series of publications by other workers which provided further evaluation of this drug. The majority of these publications, which were reviewed in an earlier paper,2 described uncontrolled trials, but three reports3-5 were concerned with studies which included controls in their evaluation of the effect of idoxuridine on herpetic keratitis. The uncontrolled trials largely confirmed the results of Kaufman et al, but the three studies which included controls were unable to show that treatment with idoxuridine was remarkably better than treatment with inert eye drops: Luntz and MacCallum,3 in an open trial comparing idoxuridine with neomycin, treated 11 cases of dendritic ulcer with idoxuridine and 11 cases with neomycin and were unable to find any striking advantage for idoxuridine. In two double-blind controlled series, . . . [Full Text PDF of this Article]


Author Affiliations

Brisbane, Australia

From the Princess Alexandra Hospital and Department of Microbiology, University of Queensland, Brisbane, Australia.


Footnotes

Submitted for publication Sept 8, 1964.

Reprint requests to Department of Dental Research, Philadelphia General Hospital, 34th St and Curie Ave, Philadelphia, Pa 19104 (Dr. Brightman); or 137 Wickham Terrace, Brisbane, Australia (Dr. Hart).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1965 American Medical Association. All Rights Reserved.